世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い



アジア太平洋地域の止血剤・組織シーラント市場予測 2019-2027年

ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027

 

出版社 出版日電子媒体価格ページ数
Inkwood Research
インクウッドリサーチ
2018年12月 US$ 1,250
シングルユーザライセンス(印刷不可PDF)
77p

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートはアジア太平洋地域の止血剤・組織シーラント市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The regional market for hemostats and tissue sealants has been estimated to burgeon at 9.65% CAGR and is expected to reach $ xx million by 2027. The primary driver for such growth is due to the improvements in government funding for subsidizing to develop and improvise new surgical sealants and hemostats.

MARKET INSIGHTS

China, India, Japan, Australia, South Korea & countries from the Rest of Asia Pacific region are considered for this market study. The Asia Pacific market is expected to witness an exponential growth for the hemostasis and sealing agents since there have been higher numbers of typical surgeries performed in hospital settings and establishments of research societies that are fostering knowledge about clinical trials and other scientific information about hemostasis and thrombosis. Also, Australia has the fastest growing market for hemostats and tissue sealants in the APAC region. This is due to the increase in population growth and healthcare expenditure.

COMPETITIVE INSIGHTS

The competing corporations involved with the hemostat and tissue sealant market are CSL Behring, Advanced Medical Solutions (AMS) Group PLC, Cryolife Inc., Baxter International Inc., B.Braun Melsungen AG, Cohera Medical Inc., Hyperbranch Medical Technology, Inc. (Acquired by Stryker), Integra Lifesciences Corp., Johnson & Johnson, Medtronic PLC, Pfizer, Inc., Smith & Nephew PLC and C.R. Bard, Inc.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. TOPICAL HEMOSTAT HOLDS THE LARGEST MARKET SHARE AND IS ANTICIPATED TO GROW AT A FASTER RATE DURING THE FORECAST PERIOD
3.2.2. SYNTHETIC TISSUE SEALANTS OF THE ADHESIVE AND TISSUE SEALANTS HOLDS THE LARGEST MARKET SHARE
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.1.1. INCREASING INCIDENCE OF CHRONIC DISEASES
4.1.2. INCREASE IN AGING POPULATION
4.1.3. INCREASE IN NUMBER OF SURGERIES
4.2. MARKET RESTRAINTS
4.2.1. STRINGENT REGULATIONS
4.2.2. ADVERSE REACTIONS AND COMPLICATIONS
4.3. MARKET OPPORTUNITIES
4.3.1. USAGE OF HEMOSTASIS DEVICES AND TISSUE SEALANTS IN MULTIPLE CONDITIONS
4.3.2. ACCESSIBILITY OF MORE TREATMENT OPTIONS FOR MEDICAL PROFESSIONALS
4.4. MARKET CHALLENGES
4.4.1. LIMITATIONS ASSOCIATED WITH HEMOSTATS AND TISSUE SEALANTS
4.4.2. PRODUCT SIDE EFFECTS AND FDA SCRUTINY
5. MARKET BY PRODUCTS
5.1. TOPICAL HEMOSTAT
5.1.1. MECHANICAL HEMOSTATS
5.1.2. ACTIVE HEMOSTATS
5.1.3. FLOWABLE HEMOSTATS
5.2. ADHESIVE AND TISSUE SEALANTS
5.2.1. SYNTHETIC TISSUE SEALANT
5.2.1.1. OXIDIZED REGENERATED CELLULOSE
5.2.1.2. CYANOACRYLATE ADHESIVES
5.2.1.3. OTHER SYNTHETIC TISSUE SEALANTS
5.2.2. NATURAL TISSUE SEALANT
5.2.2.1. CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
5.2.2.2. OTHER NATURAL TISSUE SEALANT
5.2.3. ADHESION BARRIER PRODUCTS
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE
6.1.3. BARGAINING POWER OF SUPPLIERS
6.1.4. BARGAINING POWER OF BUYERS
6.1.5. THREAT OF COMPETITIVE RIVALRY
6.2. POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL SWOT ANALYSIS OF HEMOSTATS AND TISSUE SEALANTS MARKET
6.2.1. POLITICAL & LEGAL
6.2.2. ECONOMIC
6.2.3. TECHNOLOGICAL
6.3. MARKET TRENDS
6.4. OPPORTUNITY MATRIX
7. GEOGRAPHICAL ANALYSIS
7.1. ASIA PACIFIC
7.1.1. JAPAN
7.1.2. CHINA
7.1.3. INDIA
7.1.4. AUSTRALIA
7.1.5. SOUTH KOREA
7.1.6. REST OF ASIA PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. MARKET POSITION ANALYSIS
8.2. COMPANY PROFILES
8.2.1. ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCT PORTFOLIO
8.2.1.3. STRATEGIC INITIATIVES
8.2.2. BAXTER INTERNATIONAL INC.
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCT PORTFOLIO
8.2.2.3. SCOT ANALYSIS
8.2.2.4. STRATEGIC INITIATIVES
8.2.3. B.BRAUN MELSUNGEN AG
8.2.3.1. OVERVIEW
8.2.3.2. PRODUCT PORTFOLIO
8.2.3.3. SCOT ANALYSIS
8.2.3.4. STRATEGIC ANALYSIS
8.2.4. COHERA MEDICAL INC.
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCT PORTFOLIO
8.2.4.3. STRATEGIC INITIATIVES
8.2.5. C. R. BARD, INC.
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCT PORTFOLIO
8.2.5.3. SCOT ANALYSIS
8.2.5.4. STRATEGIC INITIATIVES
8.2.6. CRYOLIFE INC.
8.2.6.1. COMPANY OVERVIEW
8.2.6.2. PRODUCT PORTFOLIO
8.2.6.3. STRATEGIC INITIATIVES
8.2.7. CSL BEHRING
8.2.7.1. COMPANY OVERVIEW
8.2.7.2. PRODUCT PORTFOLIO
8.2.7.3. STRATEGIC INITIATIVES
8.2.8. HYPERBRANCH MEDICAL TECHNOLOGY, INC. (ACQUIRED BY STRYKER)
8.2.8.1. COMPANY OVERVIEW
8.2.8.2. PRODUCT PORTFOLIO
8.2.8.3. STRATEGIC INITIATIVES
8.2.9. INTEGRA LIFESCIENCES CORP
8.2.9.1. COMPANY OVERVIEW
8.2.9.2. PRODUCT PORTFOLIO
8.2.9.3. SCOT ANALYSIS
8.2.9.4. STRATEGIC INITIATIVES
8.2.10. JOHNSON AND JOHNSON
8.2.10.1. COMPANY OVERVIEW
8.2.10.2. PRODUCT PORTFOLIO
8.2.10.3. SCOT ANALYSIS
8.2.10.4. STRATEGIC INITIATIVES
8.2.11. MEDTRONIC PLC
8.2.11.1. COMPANY OVERVIEW
8.2.11.2. PRODUCT PORTFOLIO
8.2.11.3. SCOT ANALYSIS
8.2.11.4. STRATEGIC INITIATIVES
8.2.12. PFIZER, INC.
8.2.12.1. COMPANY PROFILES
8.2.12.2. PRODUCT PORTFOLIO
8.2.12.3. SCOT ANALYSIS
8.2.12.4. STRATEGIC INITIATIVES
8.2.13. SMITH AND NEPHEW PLC
8.2.13.1. MARKET OVERVIEW
8.2.13.2. PRODUCT PORTFOLIO
8.2.13.3. SCOT ANALYSIS
8.2.13.4. STRATEGIC INITIATIVE
8.2.14. ZIMMER BIOMET HOLDINGS INC
8.2.14.1. MARKET OVERVIEW
8.2.14.2. PRODUCT PORTFOLIO
8.2.14.3. SCOT ANALYSIS
8.2.14.4. STRATEGIC INITIATIVES


LIST OF TABLES
TABLE 1 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 2 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC TOPICAL HEMOSTAT MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC MECHANICAL HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC ACTIVE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC FLOWABLE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC OXIDIZED REGENERATED CELLULOSE MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC CYANOACRYLATE ADHESIVES MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC OTHER SYNTHETIC TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC OTHER NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC ADHESION BARRIER PRODUCTS MARKET BY REAGENTS 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 HEMOSTATS COMPANY MARKET POSITION ANALYSIS 2017 (%)
TABLE 22 TISSUE SEALANTS COMPANY MARKET POSITION ANALYSIS 2017 (%)
LIST OF FIGURES
FIGURE 1 PROCESS OF COAGULATION
FIGURE 2 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2018-2026 ($ MILLION)
FIGURE 3 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
FIGURE 4 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY TOPICAL HEMOSTAT 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY MECHANICAL HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY ACTIVE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY FLOWABLE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY ADHESIVE AND TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY SYNTHETIC TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 10 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY OXIDIZED REGENERATED CELLULOSE 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY CYANOACRYLATE ADHESIVES 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY OTHER SYNTHETIC TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET BY CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT 2019-2027 ($ MILLION)
FIGURE 15 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET BY CHITIN AND OTHER NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY ADHESION BARRIER PRODUCTS 2019-2027 ($ MILLION)
FIGURE 17 PORTER’S FIVE FORCE MODEL
FIGURE 18 JAPAN HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 19 CHINA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 20 INDIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 21 AUSTRALIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 22 SOUTH KOREA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 23 REST OF ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

List of Tables

LIST OF TABLES
TABLE 1 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 2 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC TOPICAL HEMOSTAT MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC MECHANICAL HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC ACTIVE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC FLOWABLE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC OXIDIZED REGENERATED CELLULOSE MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC CYANOACRYLATE ADHESIVES MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC OTHER SYNTHETIC TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC OTHER NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC ADHESION BARRIER PRODUCTS MARKET BY REAGENTS 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 HEMOSTATS COMPANY MARKET POSITION ANALYSIS 2017 (%)
TABLE 22 TISSUE SEALANTS COMPANY MARKET POSITION ANALYSIS 2017 (%)

List of Figures

LIST OF FIGURES
FIGURE 1 PROCESS OF COAGULATION
FIGURE 2 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2018-2026 ($ MILLION)
FIGURE 3 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
FIGURE 4 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY TOPICAL HEMOSTAT 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY MECHANICAL HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY ACTIVE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY FLOWABLE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY ADHESIVE AND TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY SYNTHETIC TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 10 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY OXIDIZED REGENERATED CELLULOSE 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY CYANOACRYLATE ADHESIVES 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY OTHER SYNTHETIC TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET BY CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT 2019-2027 ($ MILLION)
FIGURE 15 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET BY CHITIN AND OTHER NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY ADHESION BARRIER PRODUCTS 2019-2027 ($ MILLION)
FIGURE 17 PORTER’S FIVE FORCE MODEL
FIGURE 18 JAPAN HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 19 CHINA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 20 INDIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 21 AUSTRALIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 22 SOUTH KOREA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 23 REST OF ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

 

COPYRIGHT(C) 2011-2019 DATA RESOURCES, Inc. ALL RIGHTS RESERVED.